1. Home
  2. FRO vs CYTK Comparison

FRO vs CYTK Comparison

Compare FRO & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRO
  • CYTK
  • Stock Information
  • Founded
  • FRO 1985
  • CYTK 1997
  • Country
  • FRO Cyprus
  • CYTK United States
  • Employees
  • FRO N/A
  • CYTK N/A
  • Industry
  • FRO Marine Transportation
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • FRO Consumer Discretionary
  • CYTK Health Care
  • Exchange
  • FRO Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • FRO 4.1B
  • CYTK 4.4B
  • IPO Year
  • FRO N/A
  • CYTK 2004
  • Fundamental
  • Price
  • FRO $19.15
  • CYTK $34.11
  • Analyst Decision
  • FRO Strong Buy
  • CYTK Buy
  • Analyst Count
  • FRO 3
  • CYTK 14
  • Target Price
  • FRO $23.33
  • CYTK $70.92
  • AVG Volume (30 Days)
  • FRO 2.1M
  • CYTK 1.3M
  • Earning Date
  • FRO 08-29-2025
  • CYTK 08-07-2025
  • Dividend Yield
  • FRO 9.30%
  • CYTK N/A
  • EPS Growth
  • FRO N/A
  • CYTK N/A
  • EPS
  • FRO 1.56
  • CYTK N/A
  • Revenue
  • FRO $1,899,854,000.00
  • CYTK $85,738,000.00
  • Revenue This Year
  • FRO N/A
  • CYTK $27.08
  • Revenue Next Year
  • FRO $14.38
  • CYTK $652.09
  • P/E Ratio
  • FRO $12.75
  • CYTK N/A
  • Revenue Growth
  • FRO 0.88
  • CYTK 2635.74
  • 52 Week Low
  • FRO $12.40
  • CYTK $29.31
  • 52 Week High
  • FRO $25.68
  • CYTK $59.39
  • Technical
  • Relative Strength Index (RSI)
  • FRO 52.84
  • CYTK 39.55
  • Support Level
  • FRO $18.27
  • CYTK $34.57
  • Resistance Level
  • FRO $20.69
  • CYTK $38.59
  • Average True Range (ATR)
  • FRO 0.56
  • CYTK 1.46
  • MACD
  • FRO 0.07
  • CYTK -0.44
  • Stochastic Oscillator
  • FRO 41.25
  • CYTK 9.68

About FRO Frontline Plc

Frontline PLC is an international shipping company engaged in the seaborne transportation of crude oil and oil products. Group operates through the tankers segment. The tankers segment includes crude oil tankers and product tankers. Its geographical area of operation includes Arabian Gulf, West African, the North Sea, and the Caribbean. Frontline earns revenue through voyage charters, time charters, and a finance lease. It is also involved in the charter, purchase, and sale of vessels.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: